Bibliography
- Meynadier J, Alirezai M. Systemic antibiotics for acne. Dermatology 1998;196:135-9
- Vibramycin [package insert] New York N. Pfizer, Inc. 2007
- Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology [review] therapeutics for the clinician: new reports on treatment modalities of possible interest to patient-caring physicians. Cutis 1991;48(5):411-7
- DH official FDA information side effects and uses. Available from: http://www.drugs.com/tro/doxycline-hyclate.html
- Hasan SA. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect. Cornea 2007;26(6):742-3
- Biller JA, Flores A, Buie T, et al. Tetracycline-induced esophagitis in adolescent patients. J Pediatr 1992;120:144-5
- Tzianetas I, Haabal F, Keystone JS. Short report: severe hiccups secondary to doxycycline-induced esophagitis during treatment of malaria. Am J Trop Med Hyg 1996;54:203-4
- Orr J, Pelel Y, Shahar A. Mediastinitis secondary to esophageal ulceration after doxycillin. Harefuah 1994;126(Suppl 4):193-4, 239
- Simpson MB, Pryzbylik J, Innis B, Denham MA. Hemolytic anemia after tetracycline therapy. N Engl J Med 1985;312:840-2
- Chatam WW, Ross DW. Leukemoid blood reaction to tetracycline. South Med J 1983;76:1195-6
- Pierog SH, Al Salihi FL, Cinotti D. Pseudotumor cerebri-a complication of tetracycline treatment of acne. J Adolesc Health Care 1986;7:139-40
- Trueb RM, Burg G. Acute generalized exanthematous pustulosis due to doxycycline. Dermatology 1993;186:75-8
- Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ 1989;298:1523-4
- Curley RK, Verbov JL. Stevens-Johns syndrome due to tetracyclines-a case report (doxycycline and a review of the literature. Clin Exp Dermatol 1987;12:124-5
- Epstein JH, Seibert JS. Porphyriaplike curaneous changes induced by tetracycline hydrochloride photosensibilisation. Arch Dermatol 1976;112:661-6
- Nelson, R, Parker SR. Ddxycycline-induced staining of adult teeth: the first reported case. Arch Dermatol 2006;142(8):1081-2
- Cunha BA, Sibley CM, Ristuccia AM. Review doxycycline. Ther Drug Monit 1982;4:115-35
- Berger RS. A double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gi complaints in healthy subjects given Doryx R and Vibramycin R. J Clin Pharmacol 1988;28:367-70
- Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139:459-64
- Caton JG. Evaluation of periostat for patient management. Compend Contin Educ Dent 1000;20:451-62
- Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. Cutis 2004;74:118-22
- Atridox (doxycycline hyclate) 10% in the Atrigel Delivery Systempackage insert 0476 (Rev 7 2/03). Available from: http://www.fda.gov/cder/foi/label/2003/50751scs011_atridox_lbl.pdf
- Wise RD. Submicrobial doxycycline and rosacea. Comp Ther 2007;332:78
- Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis 2007;80:113-20
- Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40 mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007;56:791-802
- Fleischer AB Jr, Dinehart S, Stough D, et al.; for the Solodyn Phase 2 and Phase 3 Study Groups. Safety and efficacy of a new extended-release formulation of minocycline. Cutis 2006;78(Suppl 4):21-31